Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2010 Jun 16;1(6):407-8.
doi: 10.1021/cn1000556.

The top prescription drugs of 2009 in the US: CNS therapeutics rank among highest grossing

Craig W Lindsley
Editorial

The top prescription drugs of 2009 in the US: CNS therapeutics rank among highest grossing

Craig W Lindsley. ACS Chem Neurosci. .

Erratum in

  • ACS Chem Neurosci. 2013 Oct 16;4(10):1414
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structures of the top prescription drugs of 2009 in the US. As always, Lipitor was the highest grossing single medication (no. 1, ∼$7.5 billion). The top 20 of 2009 consisted of seven CNS drugs: the atypical antipsychotic Serquel (no. 5, ∼$4.1 billion), the atypical antipsychotic Abilify (no. 6, ∼$3.9 billion), the atypical antipsychotic Zyprexa (no. 20, ∼$2.7 billion), the opioid analgesic OxyContin (no. 15, ∼$2.9 billion), the SNRI antidepressant Cymbalta (no. 16, ∼$2.8 billion), the SNRI antidepressant Effexor (no. 17, ∼$2.7 million), and SSRI antidepressant Lexapro (sold as a racemate, no. 18, ∼$2.7 billion).
See this image and copyright information in PMC

References

    1. Bartholow M. (2010) Top prescription drugs of 2009. Pharmacy Times, May 2010 (www.pharmacytimes.com/issue/pharmacy/2010/May2010/RxFocusTopDrugs-0510).
    1. IMS Health (April 1, 2010). www.imshealth.com
    1. Casey D. E. (1996) Seroquel (quetiapine): preclinical and clinical findings of a new antipsychotic. Exp. Opin. Invest. Drugs 5(8), 939–957for more information see: www.astrazenca-us.com.
    1. Shapiro D. A.; Renock S.; Arrington E.; Chiodo L. A.; Liu L.-X.; Sibley D. R.; Roth B. L.; Mailman R. (2003) Neuropsychopharmacology 28(8), 1400–1411for more information see: www.bms.com. - PubMed
    1. Tamminga C. A.; Kane J. M. (1997) Olanzapine (Zyprexa): Characteristics of a new antipsychotic. Exp. Opin. Invest. Drugs 6(11), 1743–1752for more information see: www.lilly.com. - PubMed

Publication types

MeSH terms